Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Leclerc

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Oncoimmunology|November 18, 2024
Systemic administration of a viral nanoparticle neoadjuvant prevents lung metastasis development through emergency myelopoiesisLéa Bourguignon, Roxann Hétu-Arbour, Tania Charpentier, et al.
Journal of Nanobiotechnology|June 11, 2016
Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccineGervais Rioux, Damien Carignan, Alexis Russell, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2017
Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonistDamien Carignan, Sabine Herblot, Marie-Ève Laliberté-Gagné, et al.
Journal of Nanobiotechnology|June 3, 2014
PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccineGervais Rioux, Claudia Mathieu, Alexis Russell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2016
Complement Component 3 Regulates IFN-α Production by Plasmacytoid Dendritic Cells following TLR7 Activation by a Plant Virus-like NanoparticleMarie-Ève Lebel, Marie-Pierre Langlois, Jean-François Daudelin, et al.
Vaccines|June 20, 2019
Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine PlatformMarie-Ève Laliberté-Gagné, Marilène Bolduc, Ariane Thérien, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 7, 2007
Nucleotide sequence and phylogenetic analysis of a new potexvirus: Malva mosaic virusFabien Côté, Christine Paré, Nathalie Majeau, et al.
Vaccine|November 10, 2015
Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccineDamien Carignan, Ariane Thérien, Gervais Rioux, et al.
Plos One|July 13, 2011
Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticlesChristian Savard, Annie Guérin, Karine Drouin, et al.
Plos One|June 10, 2014
Fludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanismLaïla-Aïcha Hanafi, Dominique Gauchat, Jessica Godin-Ethier, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Oncoimmunology|November 18, 2024
Systemic administration of a viral nanoparticle neoadjuvant prevents lung metastasis development through emergency myelopoiesisLéa Bourguignon, Roxann Hétu-Arbour, Tania Charpentier, et al.
Journal of Nanobiotechnology|June 11, 2016
Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccineGervais Rioux, Damien Carignan, Alexis Russell, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2017
Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonistDamien Carignan, Sabine Herblot, Marie-Ève Laliberté-Gagné, et al.
Journal of Nanobiotechnology|June 3, 2014
PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccineGervais Rioux, Claudia Mathieu, Alexis Russell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2016
Complement Component 3 Regulates IFN-α Production by Plasmacytoid Dendritic Cells following TLR7 Activation by a Plant Virus-like NanoparticleMarie-Ève Lebel, Marie-Pierre Langlois, Jean-François Daudelin, et al.
Vaccines|June 20, 2019
Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine PlatformMarie-Ève Laliberté-Gagné, Marilène Bolduc, Ariane Thérien, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 7, 2007
Nucleotide sequence and phylogenetic analysis of a new potexvirus: Malva mosaic virusFabien Côté, Christine Paré, Nathalie Majeau, et al.
Vaccine|November 10, 2015
Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccineDamien Carignan, Ariane Thérien, Gervais Rioux, et al.
Plos One|July 13, 2011
Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticlesChristian Savard, Annie Guérin, Karine Drouin, et al.
Plos One|June 10, 2014
Fludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanismLaïla-Aïcha Hanafi, Dominique Gauchat, Jessica Godin-Ethier, et al.
Pageof 6